Multicentre Study For Evaluation Of The Efficacy And Safety Of Buprenorphine Transdermal Patch (SOVENOR Transdermal Patch 5mg And 10mg) In Patients With Non-malignant Pain Of Moderate Intensity Due To Osteoarthritis, Rheumatoid Arthritis, Lower Back Pain And Joint /Muscle Pain, When An Opioid Is Necessary For Obtaining Adequate Analgesia

Trial Profile

Multicentre Study For Evaluation Of The Efficacy And Safety Of Buprenorphine Transdermal Patch (SOVENOR Transdermal Patch 5mg And 10mg) In Patients With Non-malignant Pain Of Moderate Intensity Due To Osteoarthritis, Rheumatoid Arthritis, Lower Back Pain And Joint /Muscle Pain, When An Opioid Is Necessary For Obtaining Adequate Analgesia

Completed
Phase of Trial: Phase IV

Latest Information Update: 21 Jul 2016

At a glance

  • Drugs Buprenorphine (Primary)
  • Indications Back pain; Musculoskeletal pain; Pain
  • Focus Therapeutic Use
  • Sponsors Mundipharma Pharmaceuticals Sdn Bhd
  • Most Recent Events

    • 13 Aug 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top